Radnor, PA, United States of America

Elizabeth Vadas

This inventor holds 1 USPTO granted patent. Top assignees: Mineralys Therapeutics, Inc., Tanabe Pharma Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elizabeth Vadas. Retrieved from https://idiyas.com/inventor/elizabeth-vadas-s5byxf71

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elizabeth Vadas: Pharmaceutical Invention and Patent

Introduction

Elizabeth Vadas is an inventor associated with Radnor, Pennsylvania, whose work includes a patented pharmaceutical composition. Her invention addresses the formulation of a salt of a disubstituted 1,2,4-triazine compound.

Latest Patents

Vadas is associated with 1 patent, titled “Soluble Pharmaceutical Compositions Comprising Salts of Disubstituted 1,2,4-Triazine Compound.” The patent describes pharmaceutical compositions containing a salt of the specified compound and one or more excipients. The formulation is designed to avoid inducing disproportionation of the compound’s salt.

Career Highlights

Vadas’s professional affiliations include Mineralys Therapeutics, Inc. and Tanabe Pharma Corporation. Her patent reflects work in pharmaceutical formulation and the development of compositions intended to maintain the properties of an active compound.

Collaborations

Her listed coworkers include Robert McKean and Roch Thibert, reflecting professional connections in the pharmaceutical and invention fields.

Conclusion

Elizabeth Vadas’s patent focuses on a soluble pharmaceutical composition designed to prevent salt disproportionation, highlighting her contribution to pharmaceutical formulation innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…